Slightly better outcomes in visual acuity seen for short-term versus long-term delayed sequential bilateral cataract surgery<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
FRIDAY, July 2, 2021 (HealthDay News) — Immediate sequential bilateral cataract surgery (ISBCS) is associated with worse visual outcomes compared with short-interval (one to 14 days between operations) delayed sequential bilateral cataract surgery (DSBCS-14) and long-interval (15 to 90 days) DSBCS (DSBCS-90), according to a study published online June 30 in JAMA Ophthalmology<\/em>.<\/p>\n Julia P. Owen, Ph.D., from the University of Washington in Seattle, and colleagues compared refractive outcomes of 1,824,196 patients with bilateral visual acuity measurement who underwent bilateral surgery in a retrospective cohort study. Participants were categorized into three groups: ISBCS, DSBCS-14, and DSBCS-90.<\/p>\n The researchers found that after controlling for age, self-reported race, insurance status, history of age-related macular degeneration, diabetic retinopathy, and glaucoma, compared with the DSBCS-90 group, the uncorrected visual acuity (UCVA) of the first surgical eye was 0.41 letters higher and the best-corrected visual acuity (BCVA) was 0.89 letters higher in the DSBCS-14 group; the UCVA and BCVA were 2.79 and 1.64 letters lower, respectively, in the ISBCS group. For the second eye, the DSBCS-14 and ISBCS groups had UCVA and BCVA that were 0.79 and 0.48 letters higher and 1.67 and 1.88 letters lower, respectively, compared with the DSBCS-90 group.<\/p>\n “Unexpectedly, the DSBCS-14 group had similar but better visual acuity outcomes that were statistically significant compared with the DSBCS-90 group,” the authors write.<\/p>\n One author disclosed financial ties to the pharmaceutical and medical device industries.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Editorial (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n